Zusammenfassung
Vierzig Prozent aller Frühgeburten sind die Folge einer aszendierenden Infektion mit konsekutivem Amnioninfektionssyndrom (AIS). Neben infektiösen Erregern wie Mykoplasmen, Ureaplasmen, Gardnerella, Bacteroides, Streptokokken und E. coli spielen möglicherweise auch intrinsische prädisponierende immunologische Faktoren eine Rolle. Zur Prophylaxe kann im Risikokollektiv eine Zervixverschlussoperation sinnvoll sein. Ein Screening auf Vaginosen und deren Behandlung sowie die antibiotische Therapie beim frühen vorzeitigen Blasensprung sind risikomindernd. Das AIS manifestiert sich mit klinischen mütterlichen Symptomen. Bei schwerwiegender klinischer Symptomatik sollte großzügig entbunden werden.
Abstract
Ascending vaginal infections with chorioamnionitis cause 40 % of preterm deliveries. In addition to infectious agents like Mycoplasma, Ureaplasma, Gardnerella, Bacteroides, Streptococcus, and E. coli, intrinsic immunological factors also seem to play a meaningful role. Prophylactic cervical occlusion procedures can be advantageous for at-risk women. Screening and treatment of infectious vaginosis as well as antibiotics in preterm premature rupture of membranes are useful to minimize risks. Chorioamnionitis can be diagnosed based on maternal signs and symptoms. In cases of severe clinical symptoms the decision to induce labor is favored.
Literatur
Iams JD, Romero R, Culhane JF, Goldenberg RL (2008) Primary, secondary, and tertiary interventions to reduce the morbidity and mortality of preterm birth. Lancet 371:164–175
Global Burden of Disease Study 2013 Collaborators (2015) Global, regional, annational incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800
Romero R, Espinoza J, Goncalves LF, Kusanovic JP, Friel L, Hassan S (2007) The role of inflammation and infection in preterm birth. Semin Reprod Med 25:21–39
Galinsky R, Polglase GR, Hooper SB, Black MJ, Moss TJM (2013) The consequences of chorioamnionitis: preterm birth and effects on development. J Pregnancy 2013:. doi:10.1155/2013/412831
Lassi ZS, Middleton PF, Crowther C, Bhutta ZA (2015) Interventions to improve neonatal health and later survival: an overview of systematic reviews. EBioMedicine 31:983–998
Tita ATN, Andrews WW (2010) Diagnosis and management of clinical chorioamnionitis. Clin Perinatol 37:339–354
Mach P, Gellhaus A, Wicherek L, Schmidt B, Kimmig R, Kasimir-Bauer S, Köninger A (2015) Changes in the blood serum levels of the costimulatory soluble B7-H4 molecule in pregnant women during the peripartal phase. Am J Reprod Immunol 74(3):209–215
Tamblyn JA, Lissauer DM, Powell R, Coxb P, Kilby MD (2013) The immunological basis of villitis of unknown etiology – review. Placenta 34:846–855
Hansen LK, Becher N, Bastholm S, Glavind J, Ramsing M, Kim CJ, Romero R, Jensen JS, Uldbjerg N (2014) The cervical mucus plug inhibits, but does not block, the passage of ascending bacteria from the vagina during pregnancy. Acta Obstet Gynecol Scand 93:102–108
Sheiner E, Mazor-Drey E, Levy A (2009) Asymptomatic bacteriuria during pregnancy. J Matern Neonatal Med 22:423–427
Donders G, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S (2009) Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116:1315–1324
Jones HE, Harris KA, Azizia M, Bank L, Carpenter B, Hartley JC et al (2009) Differing prevalence and diversity of bacterial species in fetal membranes from very preterm and term labor. PLOS ONE 4(12):e8205. doi:10.1371/journal.pone.0008205
Sperling RS, Newton E, Gibbs RS (1988) Intraamniotic infection in low-birth-weight infants. J Infect Dis 157:113–117
Oh KJ, Lee KA, Sohn YK, Park CW, Hong JS, Romero R et al (2010) Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol 203(3):211.e1–211.e8. doi:10.1016/j.ajog.2010.03.035
Farr A, Kiss H, Holzer I, Husslein P, Hagmann M, Petricevic L (2015) Effect of asymptomatic vaginal colonization with Candida albicans on pregnancy outcome. Acta Obstet Gynecol Scand 94(9):989–996
Roberts CL, Algert CS, Rickard KL, Morris JM (2015) Treatment of vaginal candidiasis for the prevention of preterm birth: a systematic review and meta-analysis. Syst Rev 4:31
Khan ZU, Ahmad S, Al-Obaid I, Al-Sweih NA, Joseph L, Farhat D (2008) Emergence of resistance to amphotericin B and triazoles in Candida glabrata vaginal isolates in a case of recurrent vaginitis. J Chemother 20:488–491
Özer E, Ünlü M, Erşen A, Güleklı B (2013) Intrauterine fetal loss associated with Candida glabrata chorioamnionitis: report of two cases. Turk Patoloji Derg 29:77–79
Zi MYH, Longo PL, Bueno-Silva B, Mayer MPA (2014) Mechanisms involved in the association between periodontitis and complications in pregnancy. Front Public Health 2:290
Koga K, Mor G (2010) Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 63:587–600
Oner C, Schatz F, Kizilay G, Murk W, Buchwalder LF, Kayisli UA et al (2008) Progestin-inflammatory cytokine interactions affect matrix metalloproteinase-1 and -3 expression in term decidual cells: implications for treatment of chorioamnionitis-induced preterm delivery. J Clin Endocrinol Metab 93:252–259
Incerpi MH (2010) Chorio-amnionitis and postpartum endometritis. In: Goodwin TM, Montoro MN, Muderspach L, Paulson R, Roy S (Hrsg) Management of common problems in obstetrics and gynecology. Blackwell, Oxford
Han YW, Shen T, Chung P, Buhimschi IA, Buhimschi CS (2009) Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 47:38–47
Choi SJ, Park SD, Jang IH, Uh Y, Lee A (2012) The prevalence of vaginal microorganisms in pregnant women with preterm labor and preterm birth. Ann Lab Med 32:194–200
Steel JH, Malatos S, Kennea N, Edwards AD, Miles L, Duggan P et al (2005) Bacteria and inflammatory cells in fetal membranes do not always cause preterm labor. Pediatr Res 57:404–411
Leviton A, Allred EN, Kuban KCK, Hecht JL, Onderdonk AB, O’Shea TM et al (2010) Microbiologic and histologic characteristics of the extremely preterm infant’s placenta predict white matter damage and later cerebral palsy. The ELGAN study. Pediatr Res 67:95–101
Stepan M, Cobo T, Musilova I, Hornychova H, Jacobsson B, Kacerovsky M (2016) Maternal serum C‑reactive protein in women with preterm prelabor rupture of membranes. PLOS ONE 11:e0150217
Romero R, Yeo L, Miranda J, Hassan S, Conde-Agudelo A, Chaiworapongsa T (2013) A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med 41:27–44
Romero R, Kusanovic JP, Espinoza J, Gotsch F, Nhan-Chang CL, Erez O, Kim CJ, Khalek N, Mittal P, Goncalves LF, Schaudinn C, Hassan SS, Costerton JW (2007) What is amniotic fluid ‘sludge’? Ultrasound Obstet Gynecol 30:793–798
Hoyme UB, Saling E (2004) Efficient prematurity prevention is possible by pH-self measurement and immediate therapy of threatening ascending infection. Eur J Obstet Gynecol Reprod Biol 115:148–153
Bitzer E‑M, Schneider A, Wenzlaff P, Hoyme UB, Siegmund-Schultze E (2011) Self-testing of vaginal pH to prevent preterm delivery: a controlled trial. Dtsch Arztebl Int 108:81–86
Brocklehurst P, Gordon A, Heatley E, Milan SJ (2013) Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 31:CD000262
Sangkomkamhang US, Lumbiganon P, Prasertcharoensuk W, Laopaiboon M (2015) Antenatal lower genital tract infection screening and treatment programs for preventing preterm delivery. Cochrane Database Syst Rev 2:CD006178
Raynes-Greenow CH, Roberts CL, Bell JC, Peat B, Gilbert GL, Parker S (2011) Antibiotics for ureaplasma in the vagina in pregnancy. Cochrane Database Syst Rev 9:CD003767
Smaill FM, Vazquez JC (2015) Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 7:CD000490
Kenyon S, Boulvain M, Neilson JP (2010) Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 8:CD001058
Morris JM, Roberts CL, Bowen JR, Patterson JA, Bond DM, Algert CS et al (2015) Immediate delivery compared with expectant management after preterm pre-labour rupture of the membranes close to term (PPROMT trial): a randomised controlled trial. Lancet 6736:1–9
Seelbach-Goebel B (2013) Antibiotic therapy for premature rupture of membranes and preterm labor and effect on fetal outcome. Geburtshilfe Frauenheilkd 73:1218–1227
Flenady V, Hawley G, Stock OM, Kenyon S, Badawi N (2013) Prophylactic antibiotics for inhibiting preterm labour with intact membranes. Cochrane Database Syst Rev 12:CD000246. doi:10.1002/14651858.CD000246.pub2
Chapman E, Reveiz L, Illanes E, Bonfill Cosp X (2014) Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev. doi:10.1002/14651858.CD010976
Redelinghuys MJ, Ehlers MM, Dreyer AW, Lombaard HA, Kock MM (2014) Antimicrobial susceptibility patterns of ureaplasma species and mycoplasma hominis in pregnant women. BMC Infect Dis 14:171
Berger R, Abele H, Garnier Y, Kuon R, Rath W, Schleussner E et al (2014) Prävention der Frühgeburt mit Zerklage oder totalem Muttermundsverschluss. Frauenarzt 55:966–974
Ohnolz F, Schneider KT, Haller B, Kuschel B (2015) Indication-related effectivity of cervical occlusion techniques in women with threatening preterm birth. Z Geburtshilfe Neonatol 219:136–142
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
A. Köninger, P. Mach, R. Kimmig und E. Schleußner geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
R. Kimmig, Essen
A. Köninger, Essen
I. Mylonas, München
Rights and permissions
About this article
Cite this article
Köninger, A., Mach, P., Kimmig, R. et al. Amnioninfektionssyndrom. Gynäkologe 49, 563–568 (2016). https://doi.org/10.1007/s00129-016-3916-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-016-3916-z